|
⚲
|
| Keyboard |
| Yin Min
✚
|
|
|---|---|
| CIK # | 0001552095 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001552095] | |
| 4 | [0001552095] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Sciclone Pharmaceuticals Inc | |
| Yin Min |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Sciclone Pharmaceuticals Inc SCLN
Non-Qualified Stock Option (right to buy) · derivative
|
2014-03-14 | Grant | 50,000 | $0.00 | |
|
Sciclone Pharmaceuticals Inc SCLN
Common Stock
|
2013-08-22 | Sell | 10,938 | $5.50 | 60,159 |
|
Sciclone Pharmaceuticals Inc SCLN
Common Stock
|
2013-08-22 | Option exercise | 10,938 | $4.21 | 46,049 |
|
Sciclone Pharmaceuticals Inc SCLN
Non-Qualified Stock Option (right to buy) · derivative
|
2013-08-22 | Option exercise | 10,938 | $0.00 | |
|
Sciclone Pharmaceuticals Inc SCLN
Common Stock
|
2013-08-20 | Option exercise | 12,500 | $4.23 | 52,875 |
|
Sciclone Pharmaceuticals Inc SCLN
Common Stock
|
2013-08-20 | Sell | 12,500 | $5.50 | 68,750 |
|
Sciclone Pharmaceuticals Inc SCLN
Non-Qualified Stock Option (right to buy) · derivative
|
2013-08-20 | Option exercise | 12,500 | $0.00 | |
|
Sciclone Pharmaceuticals Inc SCLN
Non-Qualified Stock Option (right to buy) · derivative
|
2013-04-04 | Grant | 60,000 | $0.00 |